Inhibikase Therapeutics
IKT
IKT
31 hedge funds and large institutions have $163M invested in Inhibikase Therapeutics in 2024 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 7 increasing their positions, 0 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
Holders
31
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$35.6M | |
| 2 | +$20.6M | |
| 3 | +$19.9M | |
| 4 |
CC
Commodore Capital
New York
|
+$19.3M |
| 5 |
PA
Perceptive Advisors
New York
|
+$19.3M |